Title:
Calif.: Interim study for medical marijuana regulation
Message:
Yesterday, Assemblyman Tom Ammiano (D-San Francisco) cancelled a planned committee vote on AB 2312, his bill to create a new regulatory board for the state’s medical marijuana industry. Instead of voting on the bill, the Senate Committee on Business, Professions and Economic Development granted his request to study the issue of regulating the medical marijuana industry after the legislative session ends.
Assemblyman Ammiano issued a statement saying, "There is no doubt that my colleagues understand the need for this legislation, and I have a lot of faith in this committee that we can hammer out a well-balanced regulatory policy during the fall to answer calls from local governments, law enforcement, including our Attorney General, patients, and the public to enact a highly regulated system for medical marijuana and provide a clear set of rules for everybody."
The well-respected committee has a great deal of expertise in regulating professional industries and is expected to examine issues like whether regulation should fall under an existing agency or a new board. It is expected to issue a report and also hold public hearings.
Many thanks to Assemblyman Ammiano and to all the groups and individuals who moved the issue forward!
